Item 2.02. Results of Operations and Financial Condition.

On November 8, 2022, 9 Meters Biopharma, Inc. (the "Company") issued a press release providing a business update and announcing financial results for the third quarter of 2022. A copy of such release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, amended, except as shall be expressly set forth by specific reference to such filing.




Item 9.01.     Financial Statements and Exhibits.



(d) Exhibits

Exhibit No.           Description
Exhibit 99.1            Press Release dated November 8, 2022.
Exhibit 104           Cover Page Interactive Data File (embedded within the Inline XBRL
                      document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses